Mark Reid

Mark Reid Email and Phone Number

Co-Founder and Managing Director of Amivas Inc. Founder and Managing Director of Graythan Regulatory Services @ Graythan Regulatory Services
Mark Reid's Location
Australia, Australia
Mark Reid's Contact Details

Mark Reid personal email

n/a
About Mark Reid

Founder and Managing Director of Graythan Regulatory Services. A regulatory consulting operation focussed on helping established companies and startups create value along the drug development pathway right through to licensure and commercialisation.Co-Founder and Managing Director of Amivas Inc. A biopharmaceutical company based in the USA specialised in orphan, neglected tropical diseases. In this role I'm responsible for global operations including our subsidiaries in Australia, Ireland and the USA.

Mark Reid's Current Company Details
Graythan Regulatory Services

Graythan Regulatory Services

View
Co-Founder and Managing Director of Amivas Inc. Founder and Managing Director of Graythan Regulatory Services
Employees:
3
Mark Reid Work Experience Details
  • Graythan Regulatory Services
    Founder And Managing Director
    Graythan Regulatory Services Sep 2017 - Present
    Australia
    Drug development and regulatory consulting services. I work with a team of expert drug developers and have over 20 years experience in drug development including five years working in Europe. I have worked on various licensing projects including marketing applications in Australia, Europe and the US. I've also worked on several commercialisation projects and accredited biotechnology companies to trial and market genetically modified vaccines in Australia and New Zealand. Quality assurance work has involved laboratories under ISO 17025, ISO 9001 and companies under various GxPs. I have setup a Human Research Ethics Committee and four Institute Biosafety Committees to support industry.
  • Amivas Inc
    Co-Founder And Managing Director
    Amivas Inc Dec 2016 - Present
    United States
    Amivas Inc is an Australian, Canadian, and US joint venture focused on the development, manufacturing, and commercialization of therapeutics for the treatment of neglected, tropical diseases. Our primary area of development is sterile injectables. In this role I manage the parent company based in the USA and our global subsidiaries. Our first product is Artesunate for Injection for severe malaria approved by the US FDA in May 2020.
  • Clinical Network Services
    Director, Biodesk And Regulatory Affairs
    Clinical Network Services Mar 2014 - Sep 2017
    Brisbane, Australia
    I led a team to deliver preclinical drug development solutions including chemistry, manufacturing and control (CMC), toxicology and clinical consultancy for our clients in Europe, the USA, Australia, SE Asia and New Zealand. The BioDesk team also provided dossier writing and submission services for marketing applications in Australia, Europe and New Zealand from our offices in Australia, Europe and the USA.
  • Clinical Network Services
    Associate Director, Biodesk And Regulatory Affairs
    Clinical Network Services Jan 2013 - Mar 2014
    Brisbane Area, Australia
    In this role, I work with a team to deliver preclinical drug development solutions including chemistry, manufacturing and control (CMC), toxicology and clinical consultancy for our clients in Europe, the USA, Australia and New Zealand. I also provide standard regulatory affairs services for registration of products in Australia with the TGA and MedSafe in New Zealand. In addition, regulatory services are also provided for the US and Europe from the team offices in Brisbane Australia; Silver Spring USA and London UK
  • Clinical Network Services
    Biodesk & Regulatory Affairs Manager
    Clinical Network Services Oct 2011 - Dec 2012
    Brisbane, Australia
    I now head up a preclinical development desk that supports biotechnology and small pharmaceutical clients develop their products for the international market. I'm also providing standard regulatory services for registration of products in Australia with the TGA and MedSafe in New Zealand.
  • Sra International
    Senior Regulatory Affairs Manager
    Sra International Jul 2010 - Nov 2011
    Didcot, Uk
    I provided regulatory affairs services in clinical trial applications, marketing authorisation applications (DCP, MRP) and other application (i.e. paediatric investigational plans, orphan drug applications, national and EMA scientific advice/protocol assistance) for European and US clients.
  • Sra International
    Regulatory Affairs Manager
    Sra International Jul 2007 - Jul 2010
    Didcot, Uk
    I provided regulatory affairs services in clinical trial applications and other application (i.e. orphan drug and national scientific advice) for European and US clients.
  • Sole Trader
    Regulatory Consultant
    Sole Trader Jan 2004 - Jun 2007
    Brisbane, Australia
    In this role I provided specialised consultancy in the clinical trial and commercial distribution (DNIR and DIR licences) required for genetically modified therapies (i.e. GM Vaccines) and gene therapies in Australia and New Zealand. I also developed specialised applications for Gene Therapy Committees (GTRAP). This work was conducted outside of Australian government hours with approval in accordance with conflict management processes.
  • Australian Government
    Australian Government
    Australian Government May 1995 - May 2007
    Australia

Mark Reid Skills

Regulatory Affairs Vaccines Biologicals Clinical Trials Biotechnology Iso Microbiology Pharmaceuticals Regulatory Submissions Pharmaceutical Industry Clinical Development Biologics Oncology Fda Infectious Diseases Cmc Ctms Ich Gcp Clinical Research Laboratory Sop Immunology Pharmaceutics Cro Gcp Drug Development

Mark Reid Education Details

Frequently Asked Questions about Mark Reid

What company does Mark Reid work for?

Mark Reid works for Graythan Regulatory Services

What is Mark Reid's role at the current company?

Mark Reid's current role is Co-Founder and Managing Director of Amivas Inc. Founder and Managing Director of Graythan Regulatory Services.

What is Mark Reid's email address?

Mark Reid's email address is ma****@****.net.au

What schools did Mark Reid attend?

Mark Reid attended Australian Graduate School Of Management, University Of New South Wales, Queensland University Of Technology, The University Of Queensland.

What are some of Mark Reid's interests?

Mark Reid has interest in Children, Environment, Education, Poverty Alleviation, Science And Technology, Disaster And Humanitarian Relief, Health.

What skills is Mark Reid known for?

Mark Reid has skills like Regulatory Affairs, Vaccines, Biologicals, Clinical Trials, Biotechnology, Iso, Microbiology, Pharmaceuticals, Regulatory Submissions, Pharmaceutical Industry, Clinical Development, Biologics.

Not the Mark Reid you were looking for?

  • Mark Reid

    Director, Irrbb Quantitative Modelling & Analytics At Westpac Institutional Bank
    Sydney, Nsw
    1
    westpac.com.au
  • Mark Reid

    Sydney, Nsw
  • Mark Reid

    Director At Core Talent | Construction | Engineering | Rail | Mining | Manufacturing | Accounting & Finance | Office Support (Wa) - Blue & White Collar - Temp & Perm 0450869622 Mark.Reid@Coretalent.Com.Au
    Perth, Wa

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.